A practical reference on preclinical research: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-03-25. Anything still debated is marked as such rather than presented as settled.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
Dihexa is a synthetic peptide that has been examined in laboratory and animal research. Its design is based on angiotensin IV, a naturally occurring peptide fragment produced in the body. The short name dihexa appears in scientific papers and online discussions, while the full chemical name describes a modified peptide chain. It is not a vitamin, mineral, or plant-derived compound. Suppliers typically present it as a research chemical rather than an approved medicine.
The full name often given is N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. This name indicates a chain containing tyrosine, isoleucine, and a six-carbon amino acid derivative. Databases list a CAS Registry Number and a molecular formula for the compound. The peptide is small compared with proteins, and its structure allows it to be studied in cell cultures and animal models. Exact identity depends on the supplier's synthesis and purification process. Minor impurities can remain after synthesis.
Discussion of dihexa in online communities sometimes outpaces the scientific record. Anecdotal reports are difficult to verify and may not distinguish effects from placebo or expectation. The absence of approved human data means long-term risks remain unknown. Researchers continue to investigate related compounds and pathways. Open questions include whether animal findings translate to humans and which biological targets matter most. No consensus exists on these points. Current reviews emphasize the need for rigorous clinical research.
Most published work on dihexa consists of preclinical studies using cell cultures or rodents. Reports have described effects on synaptic connectivity and performance on cognitive tasks in some animal models. These findings are generally presented as preliminary and require independent replication. Study designs, doses, and outcome measures vary across experiments, which complicates direct comparison. No large controlled human trials have established efficacy or safety for any medical use. At present, the evidence base is limited.
| Property | Value | Notes |
|---|---|---|
| Common name | Dihexa | Shorthand used in research literature and supplier catalogs. |
| CAS Registry Number | 1401708-83-5 | Identifier assigned to the synthetic peptide. |
| Molecular formula | C27H44N4O5 | Reported formula; verify with a certificate of analysis. |
| Appearance | White to off-white powder | Typical form for lyophilized research peptides. |
| Typical storage | −20 °C or below, desiccated | Common condition for peptide stability. |
The compound originated from work on angiotensin IV, a peptide fragment of the renin-angiotensin system. Researchers modified angiotensin IV-related structures to produce molecules with altered stability and activity. Dihexa emerged from that effort and was reported to promote dendritic spine growth in cultured neurons. Some studies link its effects to hepatocyte growth factor signaling and the c-Met receptor, while other work points to insulin-regulated aminopeptidase. The precise primary target remains a subject of investigation, and findings may depend on cell type, assay conditions, and species.
In animal research, dihexa has been administered through several routes, and reports describe improved performance on spatial learning and memory tasks in rodents. These results are frequently cited in discussions of nootropic compounds. However, species differences, small sample sizes, and varied testing protocols limit how far the findings can be generalized. No large randomized controlled trials in humans have established efficacy or long-term safety. Claims about human cognitive enhancement therefore remain speculative, and the compound is best described as an experimental laboratory substance rather than a proven therapeutic or supplement.
Dihexa is a synthetic compound studied in laboratory and animal models for effects on synaptic connectivity and cognitive performance. It is often described as a peptide analog because its structure incorporates amino acid residues linked to a hexanoic acid group. The molecule is not a naturally occurring human hormone or neurotransmitter. Its name appears in research literature and online discussions, but it has not been approved as a medicine by major regulatory agencies. Most information comes from preclinical experiments rather than controlled human trials.
Analytical confirmation generally combines a separation method with a detection method. Reverse-phase high-performance liquid chromatography can assess purity, while mass spectrometry supports molecular identity. For research-grade material, a certificate of analysis may report a batch-specific purity value, but it does not guarantee biological activity or safety. Regulatory frameworks vary by country; many jurisdictions treat dihexa as a research chemical not intended for human consumption. Purchasers should verify local rules and supplier documentation. The absence of official standards makes independent testing and careful record-keeping important for laboratory work.
In laboratory settings, dihexa is typically handled as a research chemical rather than a pharmaceutical product. Suppliers may provide it as a lyophilized powder or in solution, and purity is often stated as a percentage determined by chromatographic analysis. Because independent verification is uncommon, researchers generally rely on certificates of analysis, which may include high-performance liquid chromatography and mass spectrometry data. The absence of pharmacopeial monographs means that identity, purity, and impurity profiles can vary between batches and suppliers.
=== Death domain === Telliez and colleagues, in a bioinformatics search for proteins possessing a death domain that resembles the one found in human receptor-interacting serine/threonine kinase 1 (RIPK1, also known as RIP1), discovered a protein and named it LRDD based on its structural characteristics. Through sequence analysis, it was discovered to contain leucine-rich repeats (LRRs) at the N-terminal region, ZU5 domains (found in ZO-1 and Unc5-like netrin receptors) in the middle section, and a death domain (DD) at the C-terminus. Additionally, a structural domain referred to as the uncharacterized protein domain in UNC5, PIDD, and ankyrins (UPA) was also identified between the ZU5 domain and the death domain (DD).
where A is the signal (e.g. peak area) and the subscript i indicates the sample and the subscript st indicates the standard. The response factor of the standard is assigned an arbitrary factor, for example 1 or 100. Response factor of sample/Response factor of standard=RRF
The stigma placed on mental health makes many men believe showing signs of vulnerability could be considered weak. Men experience immense amounts of internalized stigma from societal expectations, causing symptoms such as isolation, depression, anxiety, and resistance to treatment.
A eukaryotic cell can be 2 to 100 times larger in diameter than a typical prokaryotic cell. Eukaryotes can be single-celled, as in diatoms (microscopic algae), or microfungi such as yeasts, or multicellular, as in animals, plants, most fungi, and seaweed (macroalgae). Multicellular organisms are made up of many different types of cell known overall as somatic cells. Eukaryotes are distinguished by the presence of a membrane-bound nucleus that gives the eukaryote its name, which means "true nut" or "true kernel", where "nut" means the nucleus. The nucleus is the largest membrane-bound organelle in the eukaryotic cell. Other organelles present in all eukaryotic cells are the endoplasmic reticulum, ribosomes, the Golgi apparatus, mitochondria, lysosomes, peroxisomes, endosomes, and vesicles. The contents of the cell are contained within a cell membrane, and together with all the membranes of the organelles (except the mitochondria) are known as the endomembrane system. All of these membranes are involved in the secretory and endocytic pathways, modifying, packaging, and transporting proteins and lipids to and from the trans Golgi network. In mammalian cells, endocytosis includes early, late, and recycling endosomes. Some eukaryotes cells including plant cells and fungi have a cell wall. Plastids including chloroplasts feature mainly in plant cells. Most cell types include vaults. There are many cell variations among the different eukaryote groups. Many cells project one or more cellular extensions.
== Structure == In bacteria, HDH is a single chain polypeptide; in fungi it is the C-terminal domain of a multifunctional enzyme which catalyses three different steps of histidine biosynthesis; and in plants it is expressed as a nuclear encoded protein precursor which is exported to the chloroplast.
Sources: en.wikipedia.org
SumoPred-PLM or SUMOylation site Prediction using Protein Language Model - An AI deep learning utility to predict based on known biological rules around SUMO2 and SUMO3 binding in human proteins incorporating knowledge from a separate pretrained PLM tool developed previously in 2021 by Elnaggar et al. known as ProtT5-XL-UniRef50. Such collaboration between multidisciplinary AI tools is becoming common practice.
=== BIT Index === The branched:isoprenoid tetraether (BIT) index relates the relative abundances of brGDGTs in a natural sample to the relative abundance of soil organic matter in that sample. It is calculated by ratioing a sum of bacterially-produced brGDGT abundances over a sum of archaeal isoGDGT abundances and is based on the fundamental idea that brGDGTs are produced most commonly in terrestrial environments (most ubiquitous in soils and peats) while archaeal isoGDGTs (particularly crenarchaeol) are produced in marine environments. While caveats and analytical uncertainties remain an issue, the BIT index is a potentially useful proxy for assessing the amount of fluvially transported soil organic matter compared to marine organic matter.
In January 2026, First Secretary of the Communist Party of Cuba Miguel Díaz-Canel strongly condemned strikes in Venezuela and the subsequent capture of President Nicolás Maduro, labeling the actions as "state terrorism". On 15 January 2026, he was present, alongside 94-year-old former Cuban leader Raúl Castro, in a ceremony in Havana to pay tribute to 32 Cuban soldiers killed in the United States intervention in Venezuela.
=== As a set === Conceptually a mole is similar to words like "pair" or "dozen". These words describe a set of identical objects—i.e. a collection or aggregate of the objects themselves, not the numbers 2 or 12. The unusual and daunting aspect of a mole is that the number of objects in the set, given by the Avogadro number, is difficult to comprehend. To be useful as a unit, the mole needs to describe the amount in a sample containing a number of atoms (or other elementary entities) that can be manipulated in an ordinary chemistry lab. Atoms are so small that not just trillions but trillions-of-trillions of atoms are needed to create an aggregate large enough to work with.
Sources: en.wikipedia.org
Dogs are prone to have adverse allergic reactions to food similar to human beings. The most common symptoms of food allergies in dogs include rashes, swelling, itchy or tender skin, and gastrointestinal upsets such as uncontrollable bowel movements and soft stools. Certain ingredients in dog food can elicit these allergic reactions. Specifically, the reactions are understood to be initiated by the protein ingredients in dog food, with sources such as beef, chicken, soy, and turkey being common causes of these allergic reactions. A number of "novel protein" dog foods are available that claim to alleviate such allergies in dogs. Hypoallergenic diets for dogs with food allergies consist of either limited ingredients, novel proteins, or hydrolyzed proteins. Limited ingredients make it possible to identify the suspected allergens causing these allergic reactions, as well as making it easy to avoid multiple ingredients if a canine is allergic to more than one. In novel protein recipes, manufacturers use ingredients which are less likely to cause allergic reactions in dogs such as lamb, fish, and rice. Hydrolyzed proteins do not come from a novel source; they could originate from chicken or soy for example. Hydrolyzed proteins become novel when they are broken apart into unrecognizable versions of themselves, making them novel to allergic gastrointestinal tracts.
== Specific varieties == Tripolite is the variety found in Tripoli, Libya. Bann clay is the variety found in the Lower Bann valley in Northern Ireland. Moler (mo-clay) is the variety found in northwestern Denmark, especially on the islands of Fur and Mors. Freshwater-derived food grade diatomaceous earth is the type used in United States agriculture for grain storage, as feed supplement, and as an insecticide. It is produced uncalcinated, has a very fine particle size, and is very low in crystal silica (<2%). Salt-water-derived pool / beer / wine filter grade is not suitable for human consumption or effective as an insecticide. Usually calcinated before being sold to remove impurities and undesirable volatile contents, it is composed of larger particles than the freshwater version and has a high crystalline silica content (>60%).
The Nobel Prize committee in 1923 credited the practical extraction of insulin to a team at the University of Toronto and awarded the Nobel Prize to two men: Frederick Banting and John Macleod. They were awarded the Nobel Prize in Physiology or Medicine in 1923 for the discovery of insulin. Banting, incensed that Best was not mentioned, shared his prize with him, and Macleod immediately shared his with James Collip. The patent for insulin was sold to the University of Toronto for one dollar. Two other Nobel Prizes have been awarded for work on insulin. British molecular biologist Frederick Sanger, who determined the primary structure of insulin in 1955, was awarded the 1958 Nobel Prize in Chemistry. Rosalyn Sussman Yalow received the 1977 Nobel Prize in Medicine for the development of the radioimmunoassay for insulin. Several Nobel Prizes also have an indirect connection with insulin. George Minot, co-recipient of the 1934 Nobel Prize for the development of the first effective treatment for pernicious anemia, had diabetes. William Castle observed that the 1921 discovery of insulin, arriving in time to keep Minot alive, was therefore also responsible for the discovery of a cure for pernicious anemia. Dorothy Hodgkin was awarded a Nobel Prize in Chemistry in 1964 for the development of crystallography, the technique she used for deciphering the complete molecular structure of insulin in 1969.
=== Suspended === Alprostadil topical (Alprox-TD; Befar; Cold Chain Vitaros; Femprox; RayVa; Room Temperature Vitaros; Virirec; Vitaros; Vytaros; WC-3036) – prostaglandin E1 (PGE1) agonist – female sexual dysfunction [67]
=== Ojibwe === The longest word in the Ojibwe language is miinibaashkiminasiganibiitoosijiganibadagwiingweshiganibakwezhigan (66 letters), meaning "blueberry pie". This literally translates to "blueberry cooked to jellied preserve that lies in layers in which the face is covered in bread".
Sources: en.wikipedia.org
Dihexa is a synthetic peptide modeled on angiotensin IV. It is used in laboratory and animal research, not as an approved medicine. Human effects remain poorly characterized.
It is produced by chemical synthesis, not extracted from plants or animals. Its design is based on a naturally occurring peptide fragment. Suppliers sell it as a research chemical.
No, dihexa is a modified analog of angiotensin IV. The two share a structural relationship but differ in chemical details. Research on one does not automatically apply to the other.
Published human trials are lacking. Most evidence comes from laboratory and animal studies. Therefore, human benefits and risks are not established.